102 related articles for article (PubMed ID: 20654512)
1. Imipramine for Cytochrome P450 Activity Determination: a Multiple-species Metabolic Probe.
Bull S; Catalani P; Garle M; Coecke S; Clothier R
Toxicol In Vitro; 1999; 13(4-5):537-41. PubMed ID: 20654512
[TBL] [Abstract][Full Text] [Related]
2. Determination of imipramine and seven of its metabolites in human liver microsomes by a high-performance liquid chromatographic method.
Zeugin TB; Brosen K; Meyer UA
Anal Biochem; 1990 Aug; 189(1):99-102. PubMed ID: 2278396
[TBL] [Abstract][Full Text] [Related]
3. Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line.
Su P; Coutts RT; Baker GB; Daneshtalab M
Xenobiotica; 1993 Nov; 23(11):1289-98. PubMed ID: 8310712
[TBL] [Abstract][Full Text] [Related]
4. Parallel pathway interactions in imipramine metabolism in rats.
Chiba M; Fujita S; Suzuki T
J Pharm Sci; 1988 Nov; 77(11):944-7. PubMed ID: 3225754
[TBL] [Abstract][Full Text] [Related]
5. Metabolic screening using on-line ultrafiltration mass spectrometry.
van Breemen RB; Nikolic D; Bolton JL
Drug Metab Dispos; 1998 Feb; 26(2):85-90. PubMed ID: 9456292
[TBL] [Abstract][Full Text] [Related]
6. Formation of cytotoxic metabolites from phenytoin, imipramine, desipramine, amitriptyline and mianserin by mouse and human hepatic microsomes.
Riley RJ; Roberts P; Kitteringham NR; Park BK
Biochem Pharmacol; 1990 Jun; 39(12):1951-8. PubMed ID: 2353936
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of lofepramine and imipramine in liver microsomes from rat and man.
Strandgården K; Gunnarsson PO
Xenobiotica; 1994 Aug; 24(8):703-11. PubMed ID: 7839694
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics.
Koyama E; Kikuchi Y; Echizen H; Chiba K; Ishizaki T
Ther Drug Monit; 1993 Jun; 15(3):224-35. PubMed ID: 8333003
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
Murray M; Field SL
Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
[TBL] [Abstract][Full Text] [Related]
10. Studies on cytochrome P450 responsible for oxidative metabolism of imipramine in human liver microsomes.
Ohmori S; Takeda S; Rikihisa T; Kiuchi M; Kanakubo Y; Kitada M
Biol Pharm Bull; 1993 Jun; 16(6):571-5. PubMed ID: 8364509
[TBL] [Abstract][Full Text] [Related]
11. Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection.
Foglia JP; Sorisio D; Perel JM
J Chromatogr; 1991 Dec; 572(1-2):247-58. PubMed ID: 1818058
[TBL] [Abstract][Full Text] [Related]
12. Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine.
Brøsen K; Zeugin T; Meyer UA
Clin Pharmacol Ther; 1991 Jun; 49(6):609-17. PubMed ID: 2060250
[TBL] [Abstract][Full Text] [Related]
13. Cerebral metabolism of imipramine and a purified flavin-containing monooxygenase from human brain.
Bhagwat SV; Bhamre S; Boyd MR; Ravindranath V
Neuropsychopharmacology; 1996 Aug; 15(2):133-42. PubMed ID: 8840349
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites.
McNeil CM; Murray M
Biochem Pharmacol; 1996 Jan; 51(1):15-20. PubMed ID: 8534263
[TBL] [Abstract][Full Text] [Related]
16. The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine.
Nguyen HQ; Callegari E; Obach RS
Drug Metab Dispos; 2016 Oct; 44(10):1569-78. PubMed ID: 27440861
[TBL] [Abstract][Full Text] [Related]
17. Further characterization of rat brain flavin-containing monooxygenase. Metabolism of imipramine to its N-oxide.
Bhagwat SV; Bhamre S; Boyd MR; Ravindranath V
Biochem Pharmacol; 1996 Jun; 51(11):1469-75. PubMed ID: 8630088
[TBL] [Abstract][Full Text] [Related]
18. Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic-mass spectrometry.
Narasimhachari N; Saady J; Friedel RO
Biol Psychiatry; 1981 Oct; 16(10):937-44. PubMed ID: 7306616
[TBL] [Abstract][Full Text] [Related]
19. Comparison of verapamil, diltiazem, and labetalol on the bioavailability and metabolism of imipramine.
Hermann DJ; Krol TF; Dukes GE; Hussey EK; Danis M; Han YH; Powell JR; Hak LJ
J Clin Pharmacol; 1992 Feb; 32(2):176-83. PubMed ID: 1613128
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of imipramine by brain microsomes: effects of inhibitors and exogenous cytochrome P450 reductase.
Sequeira DJ; Strobel HW
Brain Res; 1996 Oct; 738(1):24-31. PubMed ID: 8949923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
